CLOs on the Move

Blue Cross Blue Shield of Kansas

www.bcbsks.com

 
The largest health insurer in the state of Kansas. As a mutual insurance company, BCBSKS is owned by its policyholders. Its board of directors consists of Kansans from different areas of the state, 16 policyholders who bring to the table practical experience in business, medicine, hospital administration and education. Day-to-day operations are directed by a nine-person steering committee under the guidance of the company’s president/CEO. Customers and health care professionals have a voice in company activities through numerous advisory and liaison committees, as well as focus groups and surveys. BCBSKS is a financially secure, billion dollar company that contributes to ...
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.bcbsks.com
  • 1133 SW Topeka Boulevard
    Topeka, KS USA 66629
  • Phone: 785.291.7000

Executives

Name Title Contact Details
Clay Britton
Vice President of Legal and Compliance Services and General Counsel Profile
Dan Roehler
Chief Compliance Officer Profile
Matt All
President and Chief Executive officer Profile
Scott Raymond
Vice President of Legal Services and General Counsel Profile

Similar Companies

PAT Services

PAT Services is a Cleveland, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

The Myers Group

The Myers Group is a Duluth, GA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Versartis

Versartis, Inc. (NASDAQ: VSAR) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. The company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. Versartis` mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. Versartis is well-positioned to deliver a major innovation to the global growth hormone deficiency (GHD) market with the company`s most advanced clinical candidate, somavaratan. Somavaratan is a novel, long-acting form of recombinant human growth hormone that is in global late-stage clinical trials to treat GHD in children and adults. Twice-monthly somavaratan is intended to reduce the burden of daily injection therapy by requiring significantly fewer injections, potentially improving compliance/adherence and treatment outcomes.

STATPROBE

STATPROBE, Inc. is a Ann Arbor, MI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

SciMed

SciMed LLC is a New York, NY-based company in the Healthcare, Pharmaceuticals, & Biotech sector.